Teschner, S <br/><br/>
Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.  [electronic resource] 

 -  Transplantation proceedings   
 - 2533-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2009.06.099  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--therapeutic use<br/>BK Virus--drug effects<br/>Biopsy<br/>Dose-Response Relationship, Drug<br/>Drug Monitoring--methods<br/>Graft Rejection--epidemiology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Isoxazoles--blood<br/>Kidney Transplantation--adverse effects<br/>Leflunomide<br/>Mycophenolic Acid--analogs & derivatives<br/>Polyomavirus Infections--prevention & control<br/>Risk Factors<br/>Viral Load